Basic↦Ethics and Laws↦Human Research Ordinance↦Projects with Data and Biological Material
What is it? Why is it important?
Chapter 2 of the HRO ordinance regulates human research projects that prospectively sample or collect Biological Material (BM) and collect Health-Related personal Data (HRpD) from participants. Project aims are to:
- Answer a scientific question
- Make the data/samples available for reuse at some later date in order to answer research questions
In addition to general provisions, the HRO includes:
- The risk-categorisation of the research project based on expected risks (e.g. with A having a low and B a higher risk)
- The definition of Informed Consent (IC) procedures
- Required insurance coverage
- Ethics Committee (EC) / FOPH submission and approval
- Required safety procedures during study conduct (e.g. risk-control measures, notification of serious events)
- Notification requirements (e.g. changes or amendments, project completion or discontinuation)
What do I need to do?
In addition to general HRA responsibilities, the project leader of a chapter 2 HRO project must:
- Categorise the project based on expected risks and burdens (R&B), with category:
- A – having only minimal R&B
- B – having more than minimal R&B
- Provide insurance coverage for category B projects
- Set-up a database which guarantees data quality (e.g. traceability) and data confidentiality (e.g. data protection act)
- Take measures to protect data (e.g. coding of research data, access control, secure storage, secure data exchange)
- Define IC procedures (e.g. participant information (e.g. PIS) and recruitment)
- Ensure participants are adequately informed about the planned research project regarding:
- Expected obligations, potential safety issues, damage coverage, project results, financing
- Their right to withhold and revoke consent (regarding study participation) at any time
- Report the completion or discontinuation of a research project to EC within 90 days
More
Ensure to adhere to notification procedures, such as:
- Serious events including safety and protective measures
- Project completion or discontinuation
Multi-centre projects:
- Ensure appropriate agreements are in place between project leader and participating site(s), such as data / sample sharing agreements – DTA / MTA).
Where can I get help?
Your local CTU↧ can support you with experienced staff regarding this topic
Basel, Departement Klinische Forschung, CTU, dkf.unibas.ch
Lugano, Clinical Trials Unit, CTU-EOC, www.ctueoc.ch
Bern, Clinical Trials Unit, CTU, www.ctu.unibe.ch
Geneva, Clinical Research Center, CRC, crc.hug.ch
Lausanne, Clinical Research Center, CRC, www.chuv.ch
St. Gallen, Clinical Trials Unit, CTU, www.kssg.ch
Zürich, Clinical Trials Center, CTC, www.usz.ch
External Links
Swissethics – see in particular
- Templates and checklists
- Study protocols / Research projects with persons
References
KOFAM: Coordination portal for human research – see in particular
- Online wizard for risk categorisation
Swiss Law
HRO – see in particular articles and chapters / sections
- Art. 6 Research project purpose
- Art. 7 Categorisation and definition of minimal risks and burdens
- Chapter 2, section 2. Authorisation procedures
- Chapter 2, section 3. Notification and reporting